European Companies Search Engine

Quick Search Power Search
Tips & Tricks
Our help pages Using the Quick Search and Power Search Overview explain how to use our search engine.

4 EU fundings (total €692,736): 861190 - Pave - a Nanovaccine Approach for the Treatment of Pancreatic Cancer … BdlYear 2019 Financial Transparency System

Text

Statens Serum Institut, Copenhagen, Denmark

01/10/2019 EU funding (€14,876.12): 861190 - Pave - a Nanovaccine Approach for the Treatment of Pancreatic Cancer
01/10/2019 EU funding (€282,646): 861190 - Pave - a Nanovaccine Approach for the Treatment of Pancreatic Cancer
01/01/2019 EU funding (€297,522): Vacpath Aims to Establish a Human and Technological Infrastructure Within Europe to Boost the Development of Innovative, Protective and Safe Vaccines for Future Clinical USE.
01/04/2019 EU funding (€97,691): 848096 - Sharp JA - Strengthened International Health Regulations and Preparedness in the EU - Joint Action

DATA SERVICES

Unlock the full potential of processed company data with our API or Quarterly Exports.

This filing was translated from to English. The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: Statens Serum Institut, Copenhagen, Denmark.

Creative Commons License The visualizations for "Statens Serum Institut - 4 EU fundings (total €692,736): 861190 - Pave - a Nanovaccine Approach for the Treatment of Pancreatic Cancer …" are provided by North Data and may be reused under the terms of the Creative Commons CC-BY license.

Printing is only available to North Data premium service subscribers.
Close